69 related articles for article (PubMed ID: 14975101)
21. Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan.
Yasein N; Ahmad M; Matrook F; Nasir L; Froelicher ES
East Mediterr Health J; 2010 Apr; 16(4):375-80. PubMed ID: 20795419
[TBL] [Abstract][Full Text] [Related]
22. The metabolic syndrome among postmenopausal women in Ecuador.
Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
[TBL] [Abstract][Full Text] [Related]
23. Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.
Hamnvik OP; Liu X; Petrou M; Gong H; Chamberland JP; Kim EH; Christophi CA; Kales SN; Christiani DC; Mantzoros CS
Metabolism; 2011 Jul; 60(7):987-93. PubMed ID: 21056886
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of the metabolic syndrome, 2002.
Meigs JB
Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of components of the metabolic syndrome in schoolchildren with newly diagnosed type 2 diabetes mellitus.
Urakami T; Suzuki J; Yoshida A; Saito H; Wada M; Takahashi S; Mugishima H
Pediatr Diabetes; 2009 Dec; 10(8):508-12. PubMed ID: 19476567
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome in a Mediterranean pediatric cohort: prevalence using International Diabetes Federation-derived criteria and associations with adiponectin and leptin.
Papoutsakis C; Yannakoulia M; Ntalla I; Dedoussis GV
Metabolism; 2012 Feb; 61(2):140-5. PubMed ID: 21816444
[TBL] [Abstract][Full Text] [Related]
27. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity.
Brambilla P; Crinò A; Bedogni G; Bosio L; Cappa M; Corrias A; Delvecchio M; Di Candia S; Gargantini L; Grechi E; Iughetti L; Mussa A; Ragusa L; Sacco M; Salvatoni A; Chiumello G; Grugni G;
Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):269-76. PubMed ID: 20089384
[TBL] [Abstract][Full Text] [Related]
29. Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents.
Daratha KB; Bindler RC
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):365-70. PubMed ID: 19349566
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China.
Zeng P; Zhu X; Zhang Y; Wang S; Zhang T
Diabetes Res Clin Pract; 2011 Nov; 94(2):299-304. PubMed ID: 21920619
[TBL] [Abstract][Full Text] [Related]
31. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
32. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of the metabolic syndrome in Iranian adolescents.
Esmaillzadeh A; Mirmiran P; Azadbakht L; Etemadi A; Azizi F
Obesity (Silver Spring); 2006 Mar; 14(3):377-82. PubMed ID: 16648607
[TBL] [Abstract][Full Text] [Related]
34. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
[TBL] [Abstract][Full Text] [Related]
35. The relationship between the sibling recurrence-risk ratio and genotype relative risk.
Rybicki BA; Elston RC
Am J Hum Genet; 2000 Feb; 66(2):593-604. PubMed ID: 10677319
[TBL] [Abstract][Full Text] [Related]
36. Family aggregation of high myopia: estimation of the sibling recurrence risk ratio.
Farbrother JE; Kirov G; Owen MJ; Guggenheim JA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2873-8. PubMed ID: 15326097
[TBL] [Abstract][Full Text] [Related]
37. Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting.
Guo SW
Am J Hum Genet; 1998 Jul; 63(1):252-8. PubMed ID: 9634526
[TBL] [Abstract][Full Text] [Related]
38. Estimating sibling recurrence risk in population sample surveys.
Graubard BI; Sirken MG
Hum Hered; 2013; 76(1):18-27. PubMed ID: 23921823
[TBL] [Abstract][Full Text] [Related]
39. Sibling familial risk ratio of meningococcal disease in UK Caucasians.
Haralambous E; Weiss HA; Radalowicz A; Hibberd ML; Booy R; Levin M
Epidemiol Infect; 2003 Jun; 130(3):413-8. PubMed ID: 12825725
[TBL] [Abstract][Full Text] [Related]
40. [Orthogonal factor analysis on metabolic syndrome].
Hou XH; Jia WP; Bao YQ; Lu JX; Wu YM; Gu HL; Zuo YH; Jiang SY; Xiang KS
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):297-301. PubMed ID: 18788534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
